NumerixS Investment Technologies Inc - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
NumerixS Investment Technologies Inc ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$331,000
+110.8%
36,894
+97.3%
0.09%
+196.8%
Q4 2019$157,000
+25.6%
18,700
+107.8%
0.03%
+10.7%
Q2 2018$125,000
+495.2%
9,000
+592.3%
0.03%
+460.0%
Q4 2017$21,000
-88.6%
1,300
-89.5%
0.01%
-87.8%
Q3 2017$185,000
-15.1%
12,327
-11.3%
0.04%
+2.5%
Q1 2015$218,00013,9000.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders